Anti-huLRRC15 antibody drug conjugates and methods for their use
US10195209B2 · kind B2 · utility
1Cited by
43References
32Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 29, 2016 |
| Grant date | Feb 5, 2019 |
| Priority date | — |
| Expiry date | Dec 24, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides antibodies, antibody binding fragments, and antibody drug conjugates that bind human LRRC15, their methods of making, and their uses to treat patients having cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.